Document is current

Article History

Received: 21 November 2023

Accepted: 3 June 2024

First Online: 10 July 2024

Declarations:

:

: All authors declare no potential conflicts of interest with respect to the research, authorship, or publication of this article. This study was not supported by any external grants or funds. Dr. Ross currently receives research support through Yale University from Johnson and Johnson to develop methods of clinical trial data sharing; from the Medical Device Innovation Consortium as part of the National Evaluation System for Health Technology (NEST); from the Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program (U01FD005938); from the Agency for Healthcare Research and Quality (R01HS022882); from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) (R01HS025164, R01HL144644); and from Arnold Ventures; in addition, Dr. Ross was an expert witness at the request of Relator's attorneys, the Greene Law Firm, in a qui tam suit alleging violations of the False Claims Act and Anti-Kickback Statute against Biogen Inc. that was settled September 2022.

Free to read: This content has been made available to all.